Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...

Indivior, a pharmaceutical company, has reached a $30 million settlement to resolve a class action lawsuit filed in a U.S. court by health plans. The lawsuit alleges that the company unlawfully ...

Aug 21 (Reuters) - Indivior (INDV.L), opens new tab has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health plans accusing the drugmaker of illegally suppressing ...

Medicare Part D or Part C plans with drug coverage may cover Suboxone, a medication used to treat opioid use disorder (OUD). If you receive the drug as an inpatient or in a clinic with the help of a ...

DifGen has launched its first complex oral sublingual/buccal film—a generic to Suboxone (Buprenoprhine/Naloxone) in the U.S. market. DifGen also has successfully completed an FDA audit of its ...

Add Yahoo as a preferred source to see more of our stories on Google. The Wisconsin Department of Justice along with 40 other states and the District of Columbia has settled a lawsuit for $102.5 ...

(Reuters) - Indivior's U.S. subsidiary has filed lawsuits against firms seeking approval for generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the drugmaker's ...